Xujing Lu

405 total citations
18 papers, 300 citations indexed

About

Xujing Lu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xujing Lu has authored 18 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Xujing Lu's work include RNA modifications and cancer (4 papers), Lung Cancer Research Studies (3 papers) and Neuroendocrine Tumor Research Advances (2 papers). Xujing Lu is often cited by papers focused on RNA modifications and cancer (4 papers), Lung Cancer Research Studies (3 papers) and Neuroendocrine Tumor Research Advances (2 papers). Xujing Lu collaborates with scholars based in China, Sweden and Denmark. Xujing Lu's co-authors include Xifa Zhou, Shuyu Zhang, Judong Luo, Judong Luo, Jianping Cao, Hans Gregersen, Ghassan S. Kassab, Jingbo Zhao, Zhonghua Lu and Yang Ling and has published in prestigious journals such as PLoS ONE, American Journal of Physiology-Heart and Circulatory Physiology and Radiotherapy and Oncology.

In The Last Decade

Xujing Lu

16 papers receiving 299 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xujing Lu China 11 164 116 62 58 55 18 300
Lixin Wu China 12 176 1.1× 95 0.8× 99 1.6× 79 1.4× 28 0.5× 29 341
Ashlee K. Clark Australia 6 101 0.6× 61 0.5× 31 0.5× 42 0.7× 73 1.3× 6 260
Bifei Huang China 12 185 1.1× 91 0.8× 97 1.6× 54 0.9× 31 0.6× 30 333
Chujie Bai China 9 91 0.6× 108 0.9× 37 0.6× 146 2.5× 26 0.5× 26 307
Jieling Zheng China 10 160 1.0× 110 0.9× 166 2.7× 62 1.1× 47 0.9× 21 331
Yuichi Tsujimoto Japan 9 129 0.8× 65 0.6× 45 0.7× 108 1.9× 38 0.7× 38 314
Zan Lv China 10 169 1.0× 65 0.6× 50 0.8× 57 1.0× 26 0.5× 11 350
Xi He China 11 93 0.6× 149 1.3× 84 1.4× 98 1.7× 20 0.4× 31 312
Jintong Ji China 10 192 1.2× 81 0.7× 100 1.6× 38 0.7× 32 0.6× 12 303
S. Zúñiga Spain 9 151 0.9× 190 1.6× 188 3.0× 88 1.5× 62 1.1× 14 445

Countries citing papers authored by Xujing Lu

Since Specialization
Citations

This map shows the geographic impact of Xujing Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xujing Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xujing Lu more than expected).

Fields of papers citing papers by Xujing Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xujing Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xujing Lu. The network helps show where Xujing Lu may publish in the future.

Co-authorship network of co-authors of Xujing Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Xujing Lu. A scholar is included among the top collaborators of Xujing Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xujing Lu. Xujing Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Liu, Jun, Hong Zhu, Yichi Zhang, et al.. (2025). Multicenter deep learning–based automatic delineation of CTV and PTV in uterine malignancy CT imaging. Radiotherapy and Oncology. 214. 111212–111212.
3.
Liu, Jun, et al.. (2021). Longitudinal Change of Circulating Tumor Cells During Chemoradiation and Its Correlation with Prognosis in Advanced Nonsmall-Cell Lung Cancer Patients. Cancer Biotherapy and Radiopharmaceuticals. 38(5). 305–312. 3 indexed citations
4.
Luo, Judong, Xujing Lu, Yiting Tang, et al.. (2019). REV7 confers radioresistance of esophagus squamous cell carcinoma by recruiting PRDX2. Cancer Science. 110(3). 962–972. 29 indexed citations
5.
Zhang, Quan, Yiting Tang, Zhonghua Lu, et al.. (2018). DNA methylation enzyme inhibitor RG108 suppresses the radioresistance of esophageal cancer. Oncology Reports. 39(3). 993–1002. 23 indexed citations
6.
Luo, Judong, Zengpeng Li, Hong‐Jian Zhu, et al.. (2016). A Novel Role of Cab45-G in Mediating Cell Migration in Cancer Cells. International Journal of Biological Sciences. 12(6). 677–687. 13 indexed citations
7.
Zhang, Heping, Jiancheng Li, Wen‐Fang Cheng, et al.. (2015). RNA interference for epidermal growth factor receptor enhances the radiosensitivity of esophageal squamous cell carcinoma cell line Eca109. Oncology Letters. 10(3). 1495–1500. 5 indexed citations
8.
Wang, Feng, et al.. (2015). Management of primary gastric small cell carcinoma in China.. PubMed. 8(2). 1589–97. 9 indexed citations
9.
Luo, Judong, Lili Cao, Xin Jiang, et al.. (2014). Expression of YY1 correlates with progression and metastasis in esophageal squamous cell carcinomas. OncoTargets and Therapy. 7. 1753–1753. 14 indexed citations
10.
Yakisich, Juan Sebastián, Xujing Lu, & Judong Luo. (2014). Stemness and plasticity of lung cancer cells: paving the road for better therapy. OncoTargets and Therapy. 7. 1129–1129. 13 indexed citations
11.
Luo, Judong, Hong‐Jian Zhu, Xifa Zhou, et al.. (2014). Analysis of prognostic factors and comparison of prognostic index scores in patients with brain metastases after whole-brain radiotherapy.. PubMed. 7(12). 5217–25. 10 indexed citations
12.
Luo, Judong, Xifa Zhou, Xin Ge, et al.. (2013). Upregulation of Ying Yang 1 (YY1) suppresses esophageal squamous cell carcinoma development through heme oxygenase‐1. Cancer Science. 104(11). 1544–1551. 35 indexed citations
13.
Luo, Judong, Zhonghua Lu, Xujing Lu, et al.. (2013). OTUD5 Regulates p53 Stability by Deubiquitinating p53. PLoS ONE. 8(10). e77682–e77682. 46 indexed citations
14.
Lu, Xujing, Judong Luo, Yang Ling, et al.. (2013). Management of Small Cell Carcinoma of Esophagus in China. Journal of Gastrointestinal Surgery. 17(7). 1181–1187. 35 indexed citations
15.
Lu, Xujing, et al.. (2012). Knockdown of Insulin-Like Growth Factor I Receptor Inhibits the Growth and Enhances Chemo-Sensitivity of Liver Cancer Cells. Current Cancer Drug Targets. 12(1). 74–84. 10 indexed citations
16.
Zhu, Xiaolan, et al.. (2011). [Mechanisms of preventive effect of tetrandrine on acquired multidrug resistance in K562 cells].. PubMed. 19(2). 363–6. 1 indexed citations
17.
Lu, Xujing, et al.. (2008). [Effect of tetrandrine on the doxorubicin-induced expression of mdr1 gene in K562 cells].. PubMed. 29(7). 468–71. 2 indexed citations
18.
Lu, Xujing, et al.. (2001). Remodeling of the zero-stress state of femoral arteries in response to flow overload. American Journal of Physiology-Heart and Circulatory Physiology. 280(4). H1547–H1559. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026